Extensive skin necrosis in an elderly woman on dabigatran

Author:

Rajarajen Arun Prabhahar,Ashraf Raihan,Ahuja Nishtha,Bharati JoyitaORCID

Abstract

Dabigatran, a novel oral anticoagulant, is a direct thrombin inhibitor and is being increasingly used owing to the advantage of dosing without the need for laboratory monitoring. While extensive skin necrosis is known to be associated with oral anticoagulants such as warfarin and factor Xa inhibitors, dabigatran toxicity typically manifests with bleeding, especially in the elderly. We describe a 70-year-old woman who was prescribed dabigatran for the treatment of unprovoked deep venous thrombosis. She developed bleeding diathesis along with extensive skin necrosis and acute kidney injury shortly after commencing the drug. Haemodialysis was given in view of dabigatran toxicity and complications of kidney dysfunction which resolved promptly over a week. However, the patient succumbed to severe sepsis from secondary skin infections. It is crucial to closely monitor for signs of dabigatran toxicity, especially in the elderly patients.

Publisher

BMJ

Subject

General Medicine

Reference7 articles.

1. Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease

2. Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment;Guzman;Clin Dermatol,2020

3. Dabigatran-related leukocytoclastic vasculitis;An;BMJ Case Rep,2017

4. Dabigatran in the treatment of warfarin-induced skin necrosis: a new hope;Bakoyiannis;Case Rep Dermatol Med,2016

5. Dabigatran toxicity in acute kidney injury: hemodialysis and Idarucizumab required;McBride;Kidney Int Rep,2019

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Drugs that affect blood coagulation, fibrinolysis and hemostasis;Side Effects of Drugs Annual;2022

2. Dabigatran etexilate;Reactions Weekly;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3